Asston Pharmaceuticals' Board has approved the allotment of 2.41 Cr equity shares at Rs. 115 each, including a premium of Rs. 105. This preferential issue was made to 15 investors.

Following this allotment, the company's paid-up equity share capital has increased to Rs. 10.92 Cr, comprising 1.09 Cr shares of Rs. 10 each.

This move boosts the company's capital base, potentially funding growth or operations.